Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

781312

	registered interest
	date	31/10/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	NHS Trusts: Vending Machines
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what steps his Department has taken to ensure that sugary snacks are no longer on offer in vending machines in NHS Trust hospitals.
	tabling member constituency	Hornsey and Wood Green
	tabling member printed	Catherine West
	uin	110539
	answer	answer is ministerial correction date of answer 03/11/2017 answer text <p>National Health Service hospitals are required to meet the Government Buying Standards for Food and Catering Services through the NHS Standard Contract, and are required to develop and maintain a food and drink strategy which focuses on healthier eating across the whole hospital community.</p><p> </p><p>NHS England is also taking action on sugar reduction including a voluntary scheme to reduce the sales of sugar sweetened beverages to 10% or less of drinks sales for the whole month of March 2018. Should this prove ineffective, it will ban sales of sugar sweetened beverages from 1 July 2018.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 03/11/2017 14:36:35 answering member 4067 label Biography information for Steve Brine
	tabling member	4523 label Biography information for Catherine West

781313

	registered interest
	date	31/10/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Leukaemia: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, for what reasons ibrutinib is not prescribed on the NHS as a treatment for chronic lymphocytic leukaemia.
	tabling member constituency	Elmet and Rothwell
	tabling member printed	Alec Shelbrooke
	uin	110489
	answer	answer is ministerial correction date of answer 03/11/2017 answer text <p>The National Institute for Health and Care Excellence (NICE) published technology appraisal guidance in January 2017 that recommends ibrutinib for the treatment of chronic lymphocytic leukaemia and untreated chronic lymphocytic leukaemia with 17p deletion or TP53 mutation. Ibrutinib is routinely available to National Health Service patients for these indications in line with NICE’s recommendations if a patient’s doctor considers it to be the most appropriate treatment option.</p><p> </p><p>NICE has not been able to make a recommendation on the use of ibrutinib for use in the treatment of other patients with chronic lymphocytic leukaemia because no evidence submission was received from the product’s manufacturer. Ibrutinib is not therefore routinely commissioned for NHS patients for these other indications. NICE will review this decision if the company decides to make an evidence submission.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 03/11/2017 14:40:07 answering member 4067 label Biography information for Steve Brine
	tabling member	3997 label Biography information for Sir Alec Shelbrooke

781309

	registered interest
	date	31/10/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Patients: Transport
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, which categories of claimants of universal credit are entitled to claim help with healthcare travel costs; and whether he plans to change that entitlement.
	tabling member constituency	East Ham
	tabling member printed	Stephen Timms
	uin	110496
	answer	answer is ministerial correction date of answer 03/11/2017 answer text <p>Claimants of Universal Credit will be entitled to claim help with their National Health Service healthcare travel costs if their earnings for the most recent assessment period are below prescribed thresholds. A claimant would be entitled to claim help with their NHS healthcare travel costs if their earnings during that period were:</p><p>- £435 or less;</p><p>- £935 or less if their Universal Credit includes an element for either:</p><p>- a child; or</p><p>- limited capability for work.</p><p> </p><p>The ‘most recent assessment period’ means the assessment period that ended immediately before the date on which a claimant claimed help with their NHS healthcare travel costs. The period runs for a calendar month.</p><p> </p><p>Where claimants claim Universal Credit as a couple, the earnings threshold that applies is either the earnings of the single claimant or the joint claimants’ combined income.</p><p> </p><p>In addition, where claimants who are in receipt of an element for either a child or limited capacity for work, are responsible for a child, or a young person who is aged over 16 and under 19 who is receiving education or are in a traineeship, those children and young persons will be entitled to claim help with their NHS healthcare travel costs. Individuals aged 18 who are not receiving education and are universal credit claimants in their own right will be entitled to this benefit.</p><p> </p><p>The Department has no current plans to change these arrangements, but will keep the earnings thresholds under review on an annual basis.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 03/11/2017 14:38:32 answering member 4067 label Biography information for Steve Brine
	tabling member	163 label Biography information for Sir Stephen Timms

781417

	registered interest
	date	31/10/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Chronic Illnesses: Prescription Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, with reference to the proposals contained in the NHS England consultation entitled, Items which should not be routinely prescribed in primary care: A Consultation on guidance of CCGs, what assessment his Department has made of the potential effect of those proposals on patients with (a) inflammatory bowel disease and (b) a long-term condition.
	tabling member constituency	Birmingham, Selly Oak
	tabling member printed	Steve McCabe
	uin	110618
	answer	answer is ministerial correction date of answer 03/11/2017 answer text <p>NHS England’s consultation on draft guidance for clinical commissioning groups on a range of items that should not routinely be prescribed in primary care ended on 21 October. The draft guidance seeks to ensure that the National Health Service is able to secure best value from its use of medicines and therefore focuses on areas of prescribing that have been found to be ineffective or where there are more cost effective alternatives. A full Equality Impact Assessment was published alongside the draft guidance and a further Assessment will be published when final guidance is produced.</p><p> </p><p>We would not want to pre-empt any outcome following NHS England’s analysis of the responses it has received. However, we are assured that as part of issuing the final guidance, careful consideration will be given by NHS England to the responses to the consultation, both to ensure that particular groups of people are not disproportionately affected and that principles of best practice on clinical prescribing are adhered to.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 110619 110620 110621 110622 question first answered 03/11/2017 14:35:15 answering member 4067 label Biography information for Steve Brine
	tabling member	298 label Biography information for Steve McCabe

781418

	registered interest
	date	31/10/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, with reference to the proposals contained in the NHS England consultation entitled, Items which should not be routinely prescribed in primary care: A Consultation on guidance of CCGs, what assessment his Department has made of the potential effect of those proposals on (a) the management of urgent care services and (b) the number of hospital admissions.
	tabling member constituency	Birmingham, Selly Oak
	tabling member printed	Steve McCabe
	uin	110619
	answer	answer is ministerial correction date of answer 03/11/2017 answer text <p>NHS England’s consultation on draft guidance for clinical commissioning groups on a range of items that should not routinely be prescribed in primary care ended on 21 October. The draft guidance seeks to ensure that the National Health Service is able to secure best value from its use of medicines and therefore focuses on areas of prescribing that have been found to be ineffective or where there are more cost effective alternatives. A full Equality Impact Assessment was published alongside the draft guidance and a further Assessment will be published when final guidance is produced.</p><p> </p><p>We would not want to pre-empt any outcome following NHS England’s analysis of the responses it has received. However, we are assured that as part of issuing the final guidance, careful consideration will be given by NHS England to the responses to the consultation, both to ensure that particular groups of people are not disproportionately affected and that principles of best practice on clinical prescribing are adhered to.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 110618 110620 110621 110622 question first answered 03/11/2017 14:35:15 answering member 4067 label Biography information for Steve Brine
	tabling member	298 label Biography information for Steve McCabe

781419

	registered interest
	date	31/10/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Medical Treatments: Prescription Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, with reference to the proposals contained in the NHS England consultation entitled, Items which should not be routinely prescribed in primary care: A Consultation on guidance of CCGs, what assessment his Department has made of the potential effect of those proposals on access to medications for (a) children, (b) older people and (c) other vulnerable people.
	tabling member constituency	Birmingham, Selly Oak
	tabling member printed	Steve McCabe
	uin	110620
	answer	answer is ministerial correction date of answer 03/11/2017 answer text <p>NHS England’s consultation on draft guidance for clinical commissioning groups on a range of items that should not routinely be prescribed in primary care ended on 21 October. The draft guidance seeks to ensure that the National Health Service is able to secure best value from its use of medicines and therefore focuses on areas of prescribing that have been found to be ineffective or where there are more cost effective alternatives. A full Equality Impact Assessment was published alongside the draft guidance and a further Assessment will be published when final guidance is produced.</p><p> </p><p>We would not want to pre-empt any outcome following NHS England’s analysis of the responses it has received. However, we are assured that as part of issuing the final guidance, careful consideration will be given by NHS England to the responses to the consultation, both to ensure that particular groups of people are not disproportionately affected and that principles of best practice on clinical prescribing are adhered to.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 110618 110619 110621 110622 question first answered 03/11/2017 14:35:15 answering member 4067 label Biography information for Steve Brine
	tabling member	298 label Biography information for Steve McCabe

781420

	registered interest
	date	31/10/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Chronic Illnesses: Pre-payment
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, with reference to the proposals contained in the NHS England consultation entitled, Items which should not be routinely prescribed in primary care: A Consultation on guidance of CCGs, what assessment his Department has made of the potential effect of those proposals on patients with a long-term condition who have already purchased a prescription prepayment certificate.
	tabling member constituency	Birmingham, Selly Oak
	tabling member printed	Steve McCabe
	uin	110621
	answer	answer is ministerial correction date of answer 03/11/2017 answer text <p>NHS England’s consultation on draft guidance for clinical commissioning groups on a range of items that should not routinely be prescribed in primary care ended on 21 October. The draft guidance seeks to ensure that the National Health Service is able to secure best value from its use of medicines and therefore focuses on areas of prescribing that have been found to be ineffective or where there are more cost effective alternatives. A full Equality Impact Assessment was published alongside the draft guidance and a further Assessment will be published when final guidance is produced.</p><p> </p><p>We would not want to pre-empt any outcome following NHS England’s analysis of the responses it has received. However, we are assured that as part of issuing the final guidance, careful consideration will be given by NHS England to the responses to the consultation, both to ensure that particular groups of people are not disproportionately affected and that principles of best practice on clinical prescribing are adhered to.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 110618 110619 110620 110622 question first answered 03/11/2017 14:35:15 answering member 4067 label Biography information for Steve Brine
	tabling member	298 label Biography information for Steve McCabe

781421

	registered interest
	date	31/10/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Chronic Illnesses: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, with reference to the proposals contained in the NHS England consultation entitled, Items which should not be routinely prescribed in primary care: A Consultation on guidance of CCGs, what assessment his Department has made of the potential effect of those proposals on the medicine-taking behaviour of patients who rely on regular and multiple medications to prevent symptoms of long-term conditions.
	tabling member constituency	Birmingham, Selly Oak
	tabling member printed	Steve McCabe
	uin	110622
	answer	answer is ministerial correction date of answer 03/11/2017 answer text <p>NHS England’s consultation on draft guidance for clinical commissioning groups on a range of items that should not routinely be prescribed in primary care ended on 21 October. The draft guidance seeks to ensure that the National Health Service is able to secure best value from its use of medicines and therefore focuses on areas of prescribing that have been found to be ineffective or where there are more cost effective alternatives. A full Equality Impact Assessment was published alongside the draft guidance and a further Assessment will be published when final guidance is produced.</p><p> </p><p>We would not want to pre-empt any outcome following NHS England’s analysis of the responses it has received. However, we are assured that as part of issuing the final guidance, careful consideration will be given by NHS England to the responses to the consultation, both to ensure that particular groups of people are not disproportionately affected and that principles of best practice on clinical prescribing are adhered to.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 110618 110619 110620 110621 question first answered 03/11/2017 14:35:15 answering member 4067 label Biography information for Steve Brine
	tabling member	298 label Biography information for Steve McCabe